Back to top
more

West Pharmaceutical Services (WST)

(Delayed Data from NYSE)

$314.77 USD

314.77
496,482

-1.73 (-0.55%)

Updated Nov 4, 2024 04:00 PM ET

After-Market: $315.11 +0.34 (0.11%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth B Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (101 out of 250)

Industry: Medical - Dental Supplies

Zacks News

Bruker's (BRKR) Q3 Earnings & Revenues Surpass Estimates

Bruker's (BRKR) third-quarter 2020 results reflect dismal performances by two of the reporting segments and geographies due to coronavirus-led business disruptions.

Chemed's (CHE) Shares Up on Q3 Earnings and Revenue Beat

Chemed (CHE) reports solid revenue growth across key subsidiaries in third-quarter results.

STERIS' (STE) Earnings & Revenues Surpass Estimates in Q2

STERIS' (STE) second-quarter fiscal 2021 results reflect strong performance by the Life Sciences and the Applied Sterilization Technologies segments despite the coronavirus-led economic crisis.

Teleflex (TFX) Q3 Earnings & Revenues Beat, Decline Y/Y

Teleflex (TFX) witnesses significant sequential improvement in segmental performance on gradual recovery of the economy.

Syneos Health (SYNH) Q3 Earnings Top Estimates, Margins Up

Syneos Health (SYNH) registers sales decline in both its business segments due to slower recovery in reimbursable out-of-pocket expenses across both segments.

Illumina (ILMN) Q3 Earnings Top Estimates, Margins Decline

Illumina (ILMN) exhibits dismal segmental performance in the third quarter of 2020 due to pandemic-led business disruptions.

NuVasive (NUVA) Q3 Earnings Beat, Gross Margin Declines

NuVasive (NUVA) registers strong international performance in Q3 along with several spinal hardware product lines growing at high single digits or more.

ResMed (RMD) Q1 Earnings Surpass Estimates, Margins Rise

ResMed's (RMD) overall increase in Q1 revenues is driven by robust performance of its mask and device product portfolios on increased demand for ventilators and ventilator masks.

Exact Sciences (EXAS) Loses 5.6% Despite Beating Q3 Earnings

Exact Sciences' (EXAS) legacy screening business sees a decline in revenues in Q3 earnings.

Henry Schein (HSIC) Q3 Earnings Top Estimates, Margins Dip

Henry Schein (HSIC) sees robust segmental performance in Q3 boosted by strong rebound in sales and solid demand for PPE and COVID-19-related products.

Amedisys (AMED) Beats Q3 Earnings Estimates, Ups 2020 View

An impressive Q3 performance by Amedisys' (AMED) Home health and hospice amid the pandemic-led business disruptions buoys optimism.

Bio-Rad (BIO) Q3 Earnings Surpass Estimates, Margins Rise

Bio-Rad's (BIO) third-quarter 2020 results reflect strong performance by the Life Science segment, boosted by coronavirus-led increased testing demand.

ABC vs. WST: Which Stock Should Value Investors Buy Now?

ABC vs. WST: Which Stock Is the Better Value Option?

Integra (IART) Q3 Earnings Surpass Estimates, Margins Up

Integra's (IART) third-quarter 2020 results reflect mixed segmental performance with strong recovery trends due to coronavirus-led business disruptions.

IDEXX (IDXX) Earnings Beat Estimates in Q3, Margins Rise

IDEXX (IDXX) registered strong contribution from its CAG business in the third quarter despite pandemic-induced challenges.

Trina Mukherjee headshot

3 Dental Supplies Stocks Set to Shine on the Industry's Upturn

Despite the challenges thrown by the COVID-19 pandemic, teledentistry coupled with AI & Robotics should lend support to the Zacks Medical - Dental Supplies industry. CAH, WST and MCK are well positioned to gain from the prospects.

QIAGEN (QGEN) Q3 Earnings Beat Estimates, FY20 Guidance Up

QIAGEN (QGEN) registeres robust revenue growth across geographies and both operating segments in Q3 despite the coronavirus-led economic crisis.

Boston Scientific (BSX) Q3 Earnings Top, Margins Decline

Boston Scientific's (BSX) Q3 earnings and revenues decline year over year but improve sequentially.

Is West Pharmaceutical Services (WST) Outperforming Other Medical Stocks This Year?

Is (WST) Outperforming Other Medical Stocks This Year?

West Pharmaceutical Services (WST) Q3 Earnings and Revenues Top Estimates

West Pharmaceutical (WST) delivered earnings and revenue surprises of 13.86% and 7.20%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

West Pharmaceutical Services (WST) Earnings Expected to Grow: Should You Buy?

West Pharmaceutical (WST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

MCK or WST: Which Is the Better Value Stock Right Now?

MCK vs. WST: Which Stock Is the Better Value Option?

Here's Why You Should Avoid Betting on Intuitive Surgical Now

Intense competition in the global MedTech space and weak operational performance weighs on Intuitive Surgical (ISRG).

Veeva's Offering Chosen by Idorsia to Drive Digital Engagement

Veeva Systems' (VEEV) Commercial Cloud selected by Idorsia to enhance its digital field force in the United States, Japan and countries across Europe.

Top Ranked Growth Stocks to Buy for September 22nd

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, September 22nd.